Genitourinary Cancer,Prostate Cancer ERLIN2 & CDK5RAP3: Prognostic & Immunologic Significance in PCa Apr 23, 2024
Genitourinary Cancer,Prostate Cancer QoL in ARNEO: Degarelix + Apalutamide vs Degarelix + Placebo Apr 23, 2024
Genitourinary Cancer,Prostate Cancer sRP's Impact on HRQOL in PCa Patients Post RT and FT Apr 22, 2024
Genitourinary Cancer,Prostate Cancer Race-Specific AR Pathways in PC: Potential Insights Apr 19, 2024
Genitourinary Cancer,Prostate Cancer Cardiovascular Risks of AA and ENZ in PC: Real-World Evidence Apr 15, 2024
Genitourinary Cancer,Prostate Cancer Prostate Cancer Survival Trends: Stage-Specific Analysis Apr 15, 2024
Genitourinary Cancer,Prostate Cancer p53 Aberrations Linked to Androgen Resistance in PCa Apr 11, 2024
